Insilico Medicine develops AI-based drug discovery platform

This article was originally published here

The Maryland-based Insilico Medicine claimed that GENTRL can fast track the drug discovery process from years to days. The company is said to have validated the AI technology

The post Insilico Medicine develops AI-based drug discovery platform appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply